Abstract

BackgroundAs a significant cause of cancer deaths worldwide, breast cancer continues to be a troublesome malignancy. Long non-coding RNAs (lncRNAs) have been implicated in the development of breast cancer. Abnormal methylation has been associated with unfavorable breast cancer prognosis. Herein, the current study aimed to elucidate the role of lncRNA ROR in breast cancer.MethodsRT-qPCR was performed to determine whether lncRNA ROR was highly expressed in breast cancer tissues, while lncRNA ROR expression was detected in both the nuclear and cytoplasm of breast cancer cells. MCF-7 cells were subsequently introduced with oe-lncRNA ROR, sh-lncRNA ROR to explore the effects of lncRNA ROR on cell proliferation, invasion and apoptosis.ResultsRIP, RNA pull-down and ChIP assays provided evidence suggesting that lncRNA ROR recruited transmethylase MLL1 to promote H3K4 trimethylation that enhanced TIMP3 transcription. The rescue experiments demonstrated that lncRNA ROR knockdown could inhibit the progression of breast cancer via the downregulation of TIMP3. Finally, the in vivo experiment findings consistently highlighted the suppressive effects of lncRNA ROR silencing on tumor growth.ConclusionTaken together, our study demonstrates that silencing of lncRNA ROR inhibits breast cancer progression via repression of transmethylase MLL1 and TIMP3, emphasizing the potential of lncRNA ROR as a novel target against breast cancer.

Highlights

  • As a significant cause of cancer deaths worldwide, breast cancer continues to be a troublesome malignancy

  • To examine the effect of Long non-coding RNAs (lncRNAs) ROR in breast cancer, reverse transcription quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry were performed to characterize its expression in breast cancer tissues and adjacent tissues

  • The results obtained indicated that the expression of lncRNA ROR and TIMP3 was higher in breast cancer tissues than that in the adjacent tissues (p < 0.05; Fig. 1a)

Read more

Summary

Introduction

As a significant cause of cancer deaths worldwide, breast cancer continues to be a troublesome malignancy. Long non-coding RNAs (lncRNAs) have been implicated in the development of breast cancer. Breast cancer remains a significant malignant tumor mainly afflicting the female population, with studies highlighting its rank in the top three most common cancers worldwide along with colon and lung cancer [1]. Breast cancer has been emphasized as a chief cause of cancer diagnoses among women worldwide, representing approximately 15% of all cancer deaths and 25% of all diagnosed cancers in 2012 [2]. Accumulating studies continue to emphasize long non-coding RNAs (lncRNAs) as tumor inhibitors or carcinogenic factors in breast cancer, highlighting their potential as therapeutic targets for breast cancer [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call